BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belzeaux R, Lalanne L, Kieffer BL, Lutz PE. Focusing on the Opioid System for Addiction Biomarker Discovery. Trends Mol Med 2018;24:206-20. [PMID: 29396147 DOI: 10.1016/j.molmed.2017.12.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hansson AC, Gründer G, Hirth N, Noori HR, Spanagel R, Sommer WH. Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies. Neuroscience & Biobehavioral Reviews 2019;106:141-64. [DOI: 10.1016/j.neubiorev.2018.09.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
2 Lutz P, Courtet P, Calati R. The opioid system and the social brain: implications for depression and suicide. J Neurosci Res 2019;98:588-600. [DOI: 10.1002/jnr.24269] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
3 Kiyosawa N, Watanabe K, Toyama K, Ishizuka H. Circulating miRNA Signature as a Potential Biomarker for the Prediction of Analgesic Efficacy of Hydromorphone. Int J Mol Sci 2019;20:E1665. [PMID: 30987164 DOI: 10.3390/ijms20071665] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wiss DA, Avena N, Gold M. Food Addiction and Psychosocial Adversity: Biological Embedding, Contextual Factors, and Public Health Implications. Nutrients 2020;12:E3521. [PMID: 33207612 DOI: 10.3390/nu12113521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Jacques A, Chaaya N, Beecher K, Ali SA, Belmer A, Bartlett S. The impact of sugar consumption on stress driven, emotional and addictive behaviors. Neuroscience & Biobehavioral Reviews 2019;103:178-99. [DOI: 10.1016/j.neubiorev.2019.05.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 10.3] [Reference Citation Analysis]
6 Vorobyeva N, Kozlova AA. Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Front Pharmacol 2022;13:927984. [DOI: 10.3389/fphar.2022.927984] [Reference Citation Analysis]
7 Lamontagne SJ, Olmstead MC. Animal models in addiction research: A dimensional approach. Neurosci Biobehav Rev 2019;106:91-101. [PMID: 30309630 DOI: 10.1016/j.neubiorev.2018.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Darcq E, Kieffer BL. Opioid receptors: drivers to addiction? Nat Rev Neurosci 2018;19:499-514. [PMID: 29934561 DOI: 10.1038/s41583-018-0028-x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 40.3] [Reference Citation Analysis]
9 al'Absi M. The influence of stress and early life adversity on addiction: Psychobiological mechanisms of risk and resilience. Stress and Brain Health: In Clinical Conditions. Elsevier; 2020. pp. 71-100. [DOI: 10.1016/bs.irn.2020.03.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Coussens NP, Sittampalam GS, Jonson SG, Hall MD, Gorby HE, Tamiz AP, McManus OB, Felder CC, Rasmussen K. The Opioid Crisis and the Future of Addiction and Pain Therapeutics. J Pharmacol Exp Ther 2019;371:396-408. [PMID: 31481516 DOI: 10.1124/jpet.119.259408] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
11 Caputi FF, Caffino L, Candeletti S, Fumagalli F, Romualdi P. Short-term withdrawal from repeated exposure to cocaine during adolescence modulates dynorphin mRNA levels and BDNF signaling in the rat nucleus accumbens. Drug Alcohol Depend 2019;197:127-33. [PMID: 30818133 DOI: 10.1016/j.drugalcdep.2019.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Eckardt P, Bailey D, DeVon HA, Dougherty C, Ginex P, Krause-Parello CA, Pickler RH, Richmond TS, Rivera E, Roye CF, Redeker N. Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas. Nurs Outlook 2020;68:406-16. [PMID: 32279897 DOI: 10.1016/j.outlook.2020.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Sun Q, Zhao Y, Zhang K, Su H, Chen T, Jiang H, Du J, Zhong N, Yu S, Zhao M. An association study between methamphetamine use disorder with psychosis and polymorphisms in MiRNA. Neurosci Lett 2020;717:134725. [PMID: 31881254 DOI: 10.1016/j.neulet.2019.134725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Bahji A, Brietzke E, Soares C, Stuart H. Recent Advances in Biomarkers of Addiction: A Narrative Review. Canadian Journal of Addiction 2021;12:6-12. [DOI: 10.1097/cxa.0000000000000107] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]